Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors

James A. Zwiebel, Scott M. Freeman, Kenneth Cornetta, Reza Forough, Thomas Maciag, W. French Anderson

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Endothelial cells are attractive targets for gene transfer because of their immediate contact with the bloodstream, and, therefore, they might serve as vehicles for therapeutic drug delivery. Recently, we and others reported that endothelial cells of animal origin efficiently express both secretory and nonsecretory recombinant proteins (1-4). We now show that human endothelial cells are also capable of expressing a recombinant gene following transduction with retroviral vectors. Human umbilical vein endothelial cells were transduced with either the N2 or the SAX vector. Following selection with G418, cells transduced by both vectors were found to express neophosphotransferase activity, the product of the neomycin resistance gene. The fact that a recombinant gene can be readily inserted and efficiently expressed into human endothelial cells suggests that these cells may be able to serve a role in human gene therapy.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume170
Issue number1
DOIs
StatePublished - Jul 16 1990
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors'. Together they form a unique fingerprint.

Cite this